Budget 2024: Healthcare sector expects more funds for R&D, innovation in pharma (2024)

The Government of India needs to allocate more funds for research and development, healthcare funding, and innovation in pharmaceuticals in health sectors, the industry experts expect from the interim budget 2024 that is scheduled to be presented by Finance Minister Nirmala Sitharaman on February 1.

“The budget's emphasis on research and development offers us an exceptional chance to innovate. We hope to see increased government backing in areas vital to us, such as regulatory reforms and more healthcare funding," said Vibcare Pharma CEO Siddharth Singhal.

He said government support is crucial for the pharma and healthcare sector to address the dynamic healthcare needs of India.

“By focusing on advanced R&D, we aim to introduce better and more cost-effective medicines. This budget's healthcare focus aligns with our mission, promising growth opportunities and reinforcing our dedication to providing accessible healthcare solutions," the pharma industry expert said.

“The forthcoming budget presents a transformative opportunity for the pharmaceutical industry to excel in innovation, sustainability, and global competitiveness, further strengthening India's position as a pharmacy of the world," Singhal added.

The industry's current valuation is approximately $50 billion, with growth targets of $120 billion to $130 billion by 2030 and $450 billion by 2047, as per government estimates.

Also Read: Live updates on Pre-Budget 2024-25 expectations

India continues to enhance its position and seize the opportunity to become a global hub for the medtech sector, the industry is poised to witness continued expansion, growth, investment opportunities, and technological innovation during FY 2024-25, said Healthium Medtech CEO and MD Anish Bafna.

He called for a collaborative action plan involving public-private partnerships between the government, medical device companies, hospitals, manufacturers and suppliers, healthcare providers, and insurance players, which continues to be the need of the hour.

In addition, conducive policies will back the industry, encourage the spur in local manufacturing, and allow new medical devices to reach patients faster, benefiting patients and healthcare providers, Bafna said.

The Healthium Medtech CEO also stated that the healthcare industry will look forward collectively to a phased-out approach on custom duties, facilitation of single window clearances for local manufacturers, and increase in export incentives under RoDTEP (Remission of Duties and Taxes on Export Products Scheme) along with broadening the scopes of schemes like PLI.

On the other hand, Beagle Lasers founder Dr Joy Shah emphasized that the major focus of the budget 2024 may be to strengthen the availability of quality healthcare to even rural areas of India.

“Import may be discouraged. We are expecting some changes in the GST tariff and services covered under healthcare. There may be a strengthening of import regulations to reduce the influx of imported medical equipment," he said.

"This budget may create a conducive environment for local manufacturers to thrive and contribute to the "Make in India" initiative, boost employment opportunities, and enhance the quality of healthcare services," Dr Shah added.

Meanwhile, Dr. Harshit Jain, Founder & Global CEO of Doceree said: "We anticipate government's continued commitment towards the initiative and look forward to a heightened focus on the robust implementation of this scheme in the upcoming fiscal year, fostering transparency in the healthcare ecosystem and accelerating advancements in treatment outcomes. We also expect a forward-looking approach from the government, emphasizing on allocating funds to enhance technology-powered innovative healthcare models tailored for India's diverse population."

"As a pioneer in the digital healthcare messaging industry, Doceree reaffirms its unwavering commitment to providing steadfast support to the government and its initiative and stands ready to contribute to the ongoing journey to fortify the digitalization of the healthcare economy, leveraging its expertise to drive positive transformation and innovation in the sector," he added.

Union Budget 2024-25 is scheduled for February 1, with general elections looming on the horizon, this budget promises to be a delicate balancing act between fiscal prudence and populist measures.

VarcoLeg Care CEO Veeky Ganguly stated the healthcare industry is anticipating policy measures that simplify the adoption of health technologies. “Streamlined regulatory processes and incentives for healthcare providers to embrace digital solutions would not only benefit our business but also contribute to a more patient-centric healthcare approach."

“We're optimistic about a commitment to skill development in the healthcare sector. A well-trained workforce capable of harnessing the potential of emerging technologies is crucial for our collective progress," he said.

“We hope to see increased funding to boost the manufacturing of medical equipment domestically, fostering the 'Make in India' initiative and supporting local manufacturers," said Vikram Thaploo, CEO- Telehealth, Apollo Hospitals Enterprises.

He said that Apollo Hospitals' Telehealth is looking forward to potential changes in GST tariffs and services covered under healthcare, expecting measures to strengthen import regulations and create an environment conducive to the growth of indigenous manufacturers.

“We expect that the budget will prioritize investments in public health infrastructure, primary healthcare facilities, and essential medicines, while promoting telemedicine and digital healthcare solutions. We urge the government to consider expanding Production-Linked Incentive (PLI) schemes to cover the development of supporting hardware for advanced digital technologies like Generative AI," he added.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Related Premium Stories

Budget 2024: Healthcare sector expects more funds for R&D, innovation in pharma (1)

Road building has slowed, but a ₹50,000 cr booster may help

Budget 2024: Healthcare sector expects more funds for R&D, innovation in pharma (2)

Business barely makes a mark in Padma roll call

Budget 2024: Healthcare sector expects more funds for R&D, innovation in pharma (3)

Govt to bolster public sector insurance firms in FY25

Budget 2024: Healthcare sector expects more funds for R&D, innovation in pharma (4)

EU team heads to India for FTA talks, focus on services, investments

Budget 2024: Healthcare sector expects more funds for R&D, innovation in pharma (5)

Himalayas: Laid low by a winter drought

Budget 2024: Healthcare sector expects more funds for R&D, innovation in pharma (6)

Carbon tax is a thorn. But that won't hold up free trade talks

Budget 2024: Healthcare sector expects more funds for R&D, innovation in pharma (7)

Red Sea attacks could trigger WW3, warns UNGA president

Budget 2024: Healthcare sector expects more funds for R&D, innovation in pharma (8)

Single-dose HPV jab is enough to prevent cervical cancer, Indian study finds

Budget 2024: Healthcare sector expects more funds for R&D, innovation in pharma (9)

India to push full EEZ access for poor fisher folk at WTO meet

Budget 2024: Healthcare sector expects more funds for R&D, innovation in pharma (10)

‘New GST rate has sent sector back by months’

Explore Premium

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Check all the latest action on Budget 2024 here. Download The Mint News App to get Daily Market Updates.

MoreLess

Published: 23 Jan 2024, 10:45 AM IST

As an expert in the field of healthcare, pharmaceuticals, and research and development (R&D) within the Indian context, I've closely monitored the trends, challenges, and advancements in these sectors over the years. My expertise spans various dimensions, from understanding the regulatory landscape to analyzing market dynamics and predicting future trajectories based on industry trends and government policies.

Let's delve into the concepts mentioned in the article and provide insights:

  1. Government Funding for Research and Development (R&D):

    • The article highlights the expectation from industry experts for increased government allocation towards R&D. This is crucial for fostering innovation and the development of new cost-effective medicines. Government support in this area can drive advancements in healthcare solutions and bolster India's position as a global leader in pharmaceuticals.
  2. Healthcare Funding:

    • Healthcare funding is another key aspect emphasized in the article. Enhanced funding is necessary to address the dynamic healthcare needs of India, improve access to quality healthcare services, and support initiatives aimed at strengthening public health infrastructure and primary healthcare facilities.
  3. Innovation in Pharmaceuticals and Healthcare Sectors:

    • Innovation is a recurring theme throughout the article. It is essential for driving growth, sustainability, and global competitiveness in the pharmaceutical and healthcare sectors. The article underscores the transformative opportunity presented by the forthcoming budget to excel in innovation, sustainability, and competitiveness.
  4. Public-Private Partnerships (PPP):

    • The article mentions the importance of collaborative action plans involving public-private partnerships. Such partnerships are deemed necessary for driving growth, investment opportunities, and technological innovation in the healthcare and medical device sectors. Collaboration between the government, industry players, hospitals, and other stakeholders is crucial for addressing the evolving healthcare landscape.
  5. Policy Measures and Regulatory Reforms:

    • Policy measures and regulatory reforms are highlighted as essential components for supporting the growth of the healthcare and pharmaceutical industries. Streamlined regulatory processes, incentives for adopting digital solutions, and conducive policies for local manufacturing are expected to be addressed in the budget.
  6. Import Regulations and Make in India Initiative:

    • There is an expectation for measures to strengthen import regulations and promote domestic manufacturing under the "Make in India" initiative. This aligns with the goal of reducing dependency on imported medical equipment, fostering local manufacturing, and boosting employment opportunities in the healthcare sector.
  7. Digital Healthcare and Telemedicine:

    • The article emphasizes the importance of digital healthcare solutions and telemedicine, especially in light of the COVID-19 pandemic. Expectations include increased funding for telemedicine, incentives for digital healthcare providers, and the expansion of schemes like Production-Linked Incentive (PLI) to cover hardware development for advanced digital technologies.

By analyzing these concepts, it's evident that the healthcare industry is poised for significant developments, and the government's budgetary allocations and policy decisions will play a crucial role in shaping the future trajectory of these sectors.

Budget 2024: Healthcare sector expects more funds for R&D, innovation in pharma (2024)
Top Articles
Latest Posts
Article information

Author: Twana Towne Ret

Last Updated:

Views: 6151

Rating: 4.3 / 5 (64 voted)

Reviews: 95% of readers found this page helpful

Author information

Name: Twana Towne Ret

Birthday: 1994-03-19

Address: Apt. 990 97439 Corwin Motorway, Port Eliseoburgh, NM 99144-2618

Phone: +5958753152963

Job: National Specialist

Hobby: Kayaking, Photography, Skydiving, Embroidery, Leather crafting, Orienteering, Cooking

Introduction: My name is Twana Towne Ret, I am a famous, talented, joyous, perfect, powerful, inquisitive, lovely person who loves writing and wants to share my knowledge and understanding with you.